YPR108W-A Antibody

What is YPR108W-A and why is it significant for research?

YPR108W-A is a small 7.7 kDa protein of initially unknown function found in Saccharomyces cerevisiae (baker's yeast). It has been identified in association with pre-60S ribosomal particles during mass spectrometry analysis of protein complexes . Its significance stems from its association with pre-ribosomal factors like Nog1, Nog2, and Fpr4, suggesting a potential role in ribosome biogenesis or nuclear export pathways . Studies of this protein can provide insights into fundamental mechanisms of ribosome assembly and maturation, which are highly conserved cellular processes.

What are the primary applications for YPR108W-A antibodies in yeast research?

YPR108W-A antibodies are valuable tools for:

• Detection of the native protein in Western blot analyses

• Immunoprecipitation of protein complexes containing YPR108W-A

• Immunofluorescence to determine subcellular localization

• Purification of associated ribosomal complexes

• Validation of gene expression and protein interactions

These applications are particularly relevant for researchers studying ribosome biogenesis, pre-ribosomal export pathways, and nuclear-cytoplasmic transport in yeast models.

How should I validate a YPR108W-A antibody before use in experiments?

A comprehensive validation strategy should include:

• Genetic controls validation:

  • Testing on YPR108W-A knockout strains as negative controls

  • Using epitope-tagged YPR108W-A strains as positive controls

• Biochemical validation:

  • Western blotting to confirm detection of a single band at the expected 7.7 kDa size

  • Peptide competition assays to verify epitope specificity

  • Testing recombinant YPR108W-A protein as a positive control

• Independent antibody comparison:

  • Comparing results with a second antibody targeting a different YPR108W-A epitope

  • Correlating antibody detection with mRNA expression data

• Application-specific validation:

  • For immunoprecipitation: mass spectrometry confirmation of pulled-down protein

  • For immunofluorescence: co-localization with known pre-ribosomal markers

Complete validation documentation should be maintained according to best practices for antibody validation .

What criteria should I use to select a YPR108W-A antibody for my specific application?

Selection criteria should be tailored to your specific application:

Always review the complete validation data provided by manufacturers and literature references before selection .

What controls are essential when using YPR108W-A antibodies in Western blotting?

For rigorous Western blot experiments with YPR108W-A antibodies, include these essential controls:

• Positive controls:

  • Wild-type yeast lysate expressing YPR108W-A

  • Purified recombinant YPR108W-A protein (if available)

  • Lysate from YPR108W-A-tagged strain (e.g., TAP-tag, FLAG-tag)

• Negative controls:

  • YPR108W-A knockout strain lysate (if viable)

  • Secondary antibody-only control

  • Pre-immune serum control (for polyclonal antibodies)

• Specificity controls:

  • Peptide competition assay (pre-incubating antibody with immunizing peptide)

  • Comparison with alternative YPR108W-A antibody targeting different epitope

• Technical controls:

  • Loading control (e.g., actin, tubulin) to normalize protein loading

  • Molecular weight marker to confirm expected size (7.7 kDa)

  • Positive control for small proteins of similar size

• Process controls:

  • Pre-absorption controls to eliminate non-specific binding

  • Gradient gels to properly resolve small proteins like YPR108W-A

Document all controls thoroughly in your experimental records to ensure reproducibility and reliability .

How should I design experiments to study YPR108W-A association with pre-ribosomal particles?

A comprehensive experimental design would include:

• Co-immunoprecipitation studies:

  • Use anti-YPR108W-A antibodies to immunoprecipitate the protein and its associated complexes

  • Include appropriate controls (IgG, pre-immune serum)

  • Analyze co-precipitated proteins by Western blotting for known pre-ribosomal factors (Nog1, Nog2)

  • Consider mass spectrometry analysis for unbiased identification of all associated proteins

• Sucrose gradient fractionation:

  • Separate ribosomal and pre-ribosomal complexes on sucrose gradients

  • Analyze fractions by Western blotting with anti-YPR108W-A antibodies

  • Compare YPR108W-A distribution with markers for specific pre-ribosomal particles

• Reciprocal immunoprecipitation:

  • Immunoprecipitate known pre-ribosomal factors (Nog1, Nog2, Fpr4)

  • Probe for YPR108W-A co-precipitation by Western blotting

  • Compare results under different conditions (e.g., nucleotide dependence)

• Localization studies:

  • Perform immunofluorescence with anti-YPR108W-A antibodies

  • Co-stain with markers for nucleolus, nucleus, and cytoplasm

  • Analyze co-localization with pre-ribosomal markers

• Functional studies:

  • Analyze effects of YPR108W-A depletion on pre-ribosomal particle composition

  • Perform pulse-chase experiments to track ribosome maturation

This design allows for comprehensive characterization of YPR108W-A's association with pre-ribosomal particles from multiple angles .

What is the recommended protocol for immunoprecipitation with YPR108W-A antibodies?

Recommended Immunoprecipitation Protocol for YPR108W-A:

• Cell lysate preparation:

  • Grow yeast cells to mid-log phase (OD600 0.8-1.0)

  • Harvest cells and wash with ice-cold PBS

  • Resuspend in lysis buffer (25 mM Tris pH 7.5, 150 mM NaCl, 0.2% Triton X-100, protease inhibitors)

  • Lyse cells by glass bead disruption (4 minutes vortexing with intermittent cooling)

  • Clear lysate by centrifugation at 14,000 rpm, 4°C for 20 minutes

• Antibody binding:

  • Pre-clear lysate with Protein A/G beads if needed

  • Add 2-5 μg of anti-YPR108W-A antibody per mg of protein

  • For stable complexes, consider adding 5 mM ATP and ATP-regenerating system

  • Incubate at 4°C for 2 hours with gentle rotation

• Immunoprecipitation:

  • Add 25 μl of pre-washed Protein A/G beads

  • Incubate for additional 1 hour at 4°C

  • Wash beads 3 times with lysis buffer and twice with 25 mM Tris pH 7.5

  • For native complexes, consider gentler washes

• Elution:

  • For denaturing analysis: Boil beads in 2× SDS-Laemmli buffer

  • For native complex isolation: Consider competitive elution with peptide

• Analysis:

  • Analyze by SDS-PAGE and Western blotting

  • Probe for YPR108W-A (7.7 kDa) and known associated factors

  • For complex identification, consider mass spectrometry analysis

Always include appropriate controls such as non-specific IgG and input sample lanes in your analysis .

How do I optimize Western blotting conditions for detecting such a small protein (7.7 kDa)?

Detecting small proteins like YPR108W-A (7.7 kDa) requires specific optimization:

• Gel selection and preparation:

  • Use high percentage (15-20%) gels to properly resolve small proteins

  • Consider gradient gels (4-20%) to simultaneously resolve small proteins and larger controls

  • Use fresh gels to prevent diffusion of small proteins

• Sample preparation:

  • Avoid excessive heating during sample preparation (quick boil for 1-2 minutes)

  • Consider adding protease inhibitors to prevent degradation

  • Load higher amounts of protein (50-100 μg) for low-abundance proteins

• Electrophoresis conditions:

  • Run gels at lower voltage (80-100V) to improve resolution

  • Include appropriate molecular weight markers covering the low MW range

  • Monitor tracking dye to prevent small proteins from running off the gel

• Transfer optimization:

  • Use PVDF membranes with 0.2 μm pore size (rather than 0.45 μm)

  • Transfer at lower voltage (30V) overnight at 4°C

  • Consider semi-dry transfer systems for small proteins

  • Use transfer buffers with lower methanol concentration (10% vs. 20%)

• Blocking and antibody incubation:

  • Use BSA-based blocking buffers (milk proteins may mask small proteins)

  • Optimize primary antibody dilution specifically for small protein detection

  • Consider longer incubation times at 4°C

• Detection:

  • Use high-sensitivity ECL reagents

  • Consider signal enhancement systems for low-abundance proteins

  • Optimize exposure times (usually longer exposures needed)

This optimization strategy will significantly improve detection of YPR108W-A in Western blotting applications .

What should I do if I experience high background with YPR108W-A antibodies in Western blots?

High background is a common issue with antibodies to low molecular weight proteins. Follow this systematic troubleshooting approach:

• Antibody optimization:

  • Test a dilution series (typically 1:500 to 1:5000) to find optimal concentration

  • Reduce incubation time or temperature

  • Consider using a different lot or different antibody altogether

  • For polyclonal antibodies, consider affinity purification against the antigen

• Blocking improvements:

  • Test different blocking agents (5% BSA often works better than milk for small proteins)

  • Increase blocking time (from 1 hour to overnight at 4°C)

  • Add 0.1-0.3% Tween-20 to blocking buffer

  • Consider commercial blocking agents specifically designed for your application

• Washing optimization:

  • Increase number of washes (5-6 washes of 10 minutes each)

  • Use higher salt concentration in wash buffer (up to 500 mM NaCl)

  • Add 0.1-0.2% SDS to wash buffer for more stringent conditions

  • Ensure all wash steps are performed with gentle agitation

• Secondary antibody considerations:

  • Reduce secondary antibody concentration

  • Pre-absorb secondary antibody with yeast lysate

  • Test a different type or source of secondary antibody

  • Use highly cross-adsorbed secondary antibodies

• Sample preparation:

  • Ensure complete removal of cellular debris by centrifugation

  • Consider pre-clearing lysates with Protein A/G beads

  • Optimize protein extraction method for small proteins

• Membrane handling:

  • Ensure membrane doesn't dry out during the procedure

  • Cut membranes to minimize waste of antibody and focus on relevant MW regions

  • Consider using dot blots for initial antibody optimization

Document all optimization steps systematically to determine the most effective conditions for your specific experimental setup .

How can I determine if cross-reactivity is affecting my YPR108W-A antibody results?

Cross-reactivity assessment requires a systematic approach:

• Genetic validation:

  • Test antibody on YPR108W-A knockout strain (if viable)

  • Any remaining signal indicates cross-reactivity

  • Compare wild-type vs. knockout band patterns to identify specific and non-specific bands

• Peptide competition assay:

  • Pre-incubate antibody with excess immunizing peptide

  • Run parallel Western blots with competed and non-competed antibody

  • Bands that disappear in competed samples represent specific binding

  • Persistent bands indicate cross-reactivity

• Multiple antibody comparison:

  • Test a different antibody targeting another YPR108W-A epitope

  • Compare band patterns between different antibodies

  • Consistent bands across multiple antibodies suggest specific detection

• Mass spectrometry validation:

  • Immunoprecipitate with the YPR108W-A antibody

  • Analyze all precipitated proteins by mass spectrometry

  • Identify any non-YPR108W-A proteins that may be cross-reacting

• Recombinant protein testing:

  • Test antibody against purified recombinant YPR108W-A

  • Compare with signals from complex lysates

  • Differences in band patterns indicate potential cross-reactivity

• Species cross-reactivity:

  • Test antibody on lysates from different yeast species or other organisms

  • Compare with bioinformatic predictions of epitope conservation

  • Unexpected signals indicate cross-reactivity

• Epitope analysis:

  • Perform bioinformatic analysis to identify proteins with similar epitope sequences

  • Test antibody against these potential cross-reactive proteins if available

Document all cross-reactivity findings thoroughly to guide experimental interpretation and future antibody selection .

How can I use YPR108W-A antibodies to investigate pre-ribosomal export pathways?

YPR108W-A antibodies can be powerful tools for dissecting pre-ribosomal export pathways through these advanced approaches:

• Dynamic complex analysis:

  • Perform immunoprecipitation of YPR108W-A under different cellular conditions (nutrient stress, cell cycle phases)

  • Compare complex composition by mass spectrometry or Western blotting

  • Include nucleotide-dependent analyses (±ATP) to identify dynamic interactions

• Export block experiments:

  • Use temperature-sensitive export mutants (e.g., xpo1/crm1 mutants)

  • Track YPR108W-A localization and complex association during export block

  • Perform pulse-chase experiments to monitor kinetics of association with maturing pre-ribosomes

• Co-localization with export factors:

  • Perform high-resolution co-localization studies with nuclear pore complex components

  • Use triple labeling with nucleolar markers and export factors

  • Apply super-resolution microscopy techniques for detailed spatial information

• Chromatin immunoprecipitation:

  • If YPR108W-A associates with nascent pre-ribosomes, perform ChIP analysis

  • Map association with ribosomal DNA loci

  • Compare binding patterns with those of known pre-ribosomal factors

• In vitro binding assays:

  • Use purified YPR108W-A (immunoprecipitated or recombinant)

  • Test direct binding to export factors (Xpo1/Crm1, karyopherins)

  • Analyze nucleotide-dependence of these interactions

• Structure-function studies:

  • Use antibodies to map functional domains by epitope masking

  • Perform in vitro reconstitution of export complexes

  • Use antibody fragments for structural studies (cryo-EM) of export intermediates

• Kinetic analysis:

  • Perform real-time imaging with fluorescently tagged YPR108W-A

  • Use fluorescence recovery after photobleaching (FRAP) to measure dynamics

  • Correlate with antibody-based biochemical analysis of complexes

This multi-faceted approach can provide comprehensive insights into YPR108W-A's role in pre-ribosomal export pathways .

What approaches can be used to map the interaction network of YPR108W-A using antibodies?

Mapping the YPR108W-A interaction network requires integrating multiple complementary approaches:

• Sequential immunoprecipitation:

  • Perform first immunoprecipitation with anti-YPR108W-A antibody

  • Elute under native conditions

  • Perform second immunoprecipitation with antibodies against suspected interaction partners

  • This confirms direct or indirect association within the same complex

• Proximity-dependent labeling:

  • Express YPR108W-A fused to BioID or APEX2 proximity labeling enzymes

  • These enzymes biotinylate nearby proteins in living cells

  • Use anti-YPR108W-A antibodies to verify proper localization of fusion protein

  • Purify biotinylated proteins and identify by mass spectrometry

• Crosslinking immunoprecipitation (CLIP):

  • Treat cells with crosslinking reagents to stabilize transient interactions

  • Immunoprecipitate with anti-YPR108W-A antibodies

  • Analyze crosslinked complexes by mass spectrometry

  • This approach captures both stable and transient interactions

• Co-immunoprecipitation combined with siRNA:

  • Deplete suspected interaction partners using siRNA/shRNA

  • Perform immunoprecipitation with anti-YPR108W-A antibodies

  • Analyze changes in co-precipitated proteins

  • This helps establish hierarchy and dependency in complex formation

• In situ proximity ligation assay (PLA):

  • Use anti-YPR108W-A antibody together with antibodies against potential partners

  • PLA generates fluorescent signals only when proteins are in close proximity

  • This confirms interactions in their native cellular context

• Surface plasmon resonance (SPR):

  • Immobilize purified YPR108W-A (via immunoprecipitation or recombinant expression)

  • Test binding of candidate interaction partners

  • Measure binding kinetics and affinity

  • This confirms direct physical interactions

• Comparative interaction mapping:

  • Compare YPR108W-A interaction maps under different conditions

  • Identify condition-specific interactions

  • Correlate with functional data on pre-ribosomal processing

Integration of these approaches provides a robust interaction network that can be used to guide functional studies of YPR108W-A .

How can I develop a quantitative assay for YPR108W-A expression using antibodies?

Developing a quantitative assay for YPR108W-A expression requires careful optimization:

• Quantitative Western blotting:

  • Generate a standard curve using purified recombinant YPR108W-A

  • Use a range of concentrations (e.g., 0.1-100 ng)

  • Process standards alongside samples in the same gel

  • Use fluorescent secondary antibodies for wider linear range

  • Include normalization controls (actin, GAPDH) processed identically

  • Image using a digital system with linear detection range

  • Perform densitometry analysis with appropriate software

• ELISA development:

  • Create a sandwich ELISA using two antibodies recognizing different YPR108W-A epitopes

  • Use one antibody for capture and the second for detection

  • Develop a standard curve with recombinant YPR108W-A protein

  • Optimize sample dilution to ensure measurements in the linear range

  • Validate assay for specificity, sensitivity, and reproducibility

• Flow cytometry:

  • Optimize fixation and permeabilization for intracellular YPR108W-A detection

  • Use fluorescently labeled anti-YPR108W-A antibodies

  • Include isotype controls to establish background

  • Use calibration beads to standardize fluorescence intensities

  • Normalize signal to cell size/complexity parameters

• Automated image analysis:

  • Perform immunofluorescence with anti-YPR108W-A antibodies

  • Acquire images using standardized microscopy settings

  • Develop an automated image analysis pipeline to quantify signal intensity

  • Include DAPI staining for cell counting and normalization

  • Validate with samples of known YPR108W-A expression levels

• Validation requirements:

  • Determine assay range, sensitivity, and precision

  • Evaluate intra-assay and inter-assay variability

  • Establish limits of detection and quantification

  • Validate specificity using knockout controls

  • Test assay robustness with different sample preparation methods

For all quantitative assays, proper controls and validation are essential to ensure reliable and reproducible results .

What are the key considerations for reproducible YPR108W-A antibody experiments?

Ensuring reproducibility in YPR108W-A antibody experiments requires attention to several critical factors:

• Antibody validation and documentation:

  • Use only fully validated antibodies with documented specificity

  • Record complete antibody information (source, catalog number, lot, dilution)

  • Maintain consistent antibody sources and lots when possible

  • Include appropriate controls in every experiment

• Experimental standardization:

  • Develop and follow detailed standard operating procedures (SOPs)

  • Standardize sample preparation, especially for the small YPR108W-A protein

  • Use consistent reagent sources and preparation methods

  • Implement quality control checkpoints throughout protocols

• Technical considerations:

  • Optimize protocols specifically for the 7.7 kDa YPR108W-A protein

  • Use high percentage gels and appropriate transfer conditions

  • Include molecular weight markers covering the low range

  • Ensure proper resolution of small proteins

• Data analysis standardization:

  • Use consistent quantification methods

  • Apply appropriate statistical analyses

  • Report all normalization procedures in detail

  • Include raw data when publishing

• Resource sharing:

  • Share detailed protocols with the research community

  • Deposit validated antibody information in antibody databases

  • Report negative results to prevent duplication of failed approaches

By addressing these key considerations, researchers can significantly improve the reproducibility of their YPR108W-A antibody experiments and contribute to more robust scientific findings in the field .